Microbix Biosystems Inc.
MBX.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -237.90K | 1.13M | 1.40M | 2.59M | 3.75M |
| Total Depreciation and Amortization | 1.17M | 1.16M | 1.16M | 1.16M | 1.02M |
| Total Amortization of Deferred Charges | 50.40K | 50.40K | 50.40K | 25.50K | 103.80K |
| Total Other Non-Cash Items | 805.40K | 684.40K | 715.60K | 727.70K | -1.55M |
| Change in Net Operating Assets | -1.38M | -200.60K | -550.30K | -1.31M | -1.78M |
| Cash from Operations | 411.10K | 2.83M | 2.78M | 3.19M | 1.55M |
| Capital Expenditure | -625.00K | -1.02M | -1.32M | -1.20M | -1.12M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -197.80K | -197.80K | -197.80K | -197.80K |
| Cash from Investing | -625.00K | -1.22M | -1.52M | -1.40M | -1.32M |
| Total Debt Issued | -- | -- | -- | -- | 33.10K |
| Total Debt Repaid | -1.42M | -1.67M | -522.30K | -522.40K | -522.40K |
| Issuance of Common Stock | 2.82M | 2.82M | 443.40K | 363.80K | 357.30K |
| Repurchase of Common Stock | -1.84M | -1.73M | -1.38M | -925.30K | -798.70K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Cash from Financing | -335.60K | -444.60K | -1.06M | -794.80K | -685.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
| Net Change in Cash | -549.50K | 1.17M | 193.70K | 997.90K | -459.40K |